CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-11 | Norry Elliot Chief Medical Officer | Sale | −3,770 | $3.56 | $13K | 6,343 |
| 2022-01-11 | Rawcliffe Adrian Chief Executive Officer | Sale | −14,362 | $3.56 | $51K | 15,978 |
| 2022-01-04 | Bertrand William C JR Chief Operating Officer | Sale | −3,490 | $4.06 | $14K | 5,873 |
| 2022-01-04 | Lunger John Chief Patient Supply Officer | Sale | −1,070 | $4.06 | $4K | 1,755 |
| 2022-01-04 | Norry Elliot Chief Medical Officer | Sale | −849 | $4.06 | $3K | 1,388 |
| 2022-01-04 | Rawcliffe Adrian Chief Executive Officer | Sale | −5,532 | $4.06 | $22K | 6,172 |
| 2021-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,782 | $5.20 | $14K | 3,070 |
| 2021-08-02 | Lunger John Chief Patient Supply Officer | Sale | −2,939 | $3.58 | $11K | 4,873 |
| 2021-07-02 | Bertrand William C JR Chief Operating Officer | Sale | −4,375 | $4.26 | $19K | 7,329 |
| 2021-07-02 | Lunger John Chief Patient Supply Officer | Sale | −1,907 | $4.26 | $8K | 3,170 |
| 2021-06-28 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,794 | $4.37 | $12K | 3,058 |
| 2021-01-19 | Norry Elliot Chief Medical Officer | Sale | −2,111 | $5.67 | $12K | 3,539 |
| 2021-01-19 | Lunger John Chief Patient Supply Officer | Sale | −4,358 | $5.67 | $25K | 7,346 |
| 2021-01-19 | Rawcliffe Adrian Chief Executive Officer | Sale | −9,879 | $5.67 | $56K | 13,529 |
| 2021-01-12 | Bertrand William C JR Chief Operating Officer | Sale | −2,234 | $6.15 | $14K | 3,768 |
| 2021-01-12 | Lunger John Chief Patient Supply Officer | Sale | −1,058 | $6.15 | $7K | 1,767 |
| 2021-01-12 | Norry Elliot Chief Medical Officer | Sale | −841 | $6.15 | $5K | 1,396 |
| 2021-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,707 | $6.15 | $17K | 3,695 |
| 2021-01-04 | Lunger John Chief Patient Supply Officer | Sale | −1,065 | $5.33 | $6K | 1,760 |
| 2021-01-04 | Bertrand William C JR Chief Operating Officer | Sale | −3,499 | $5.33 | $19K | 5,864 |
Page 5 of 7 · 140 trades